Update
$Imunon(IMNN.US$ Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON's IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer
2 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
2 MINUTES AGO, 8:30 AM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
